AEGiS-IRIN: Kagame Visits Merck Research Laboratories

Important note: Information in this article was accurate in 2001. The state of the art may have changed since the publication date.

Kagame Visits Merck Research Laboratories

UN Integrated Regional Information Networks - September 8, 2001

Rwandan President Paul Kagame on Thursday visited Merck research laboratories in Pennsylvania, USA, and commended the company for its work in developing a number of HIV/AIDS vaccines, presidential spokesman Nicholas Shalita announced Friday. Kagame said Merck should consider Rwanda among its partners in the effort to fight AIDS, and emphasised that a wholistic approach involving prevention through public awareness, education and mass-mobilisation on the one hand, and a vaccine on the other, is required.

Executive Vice-President of Merck and head of the team of scientists working on an AIDS vaccine, Dr. Peter Kim, said that while it would be sometime before an AIDS vaccine is developed, Merck is committed to making the vaccine available to everyone who would benefit from it, once it has been developed. Kim said that Merck's efforts are currently focused on developing an AIDS vaccine that is safe, well-tolerated by humans and practical to administer, noting the vaccine should be effective against the many strains of HIV/AIDS and provide protection for a long period of time. Kim said that researchers also need to look into mechanisms for widespread immunisation once the vaccine is developed.

Also present during the visit were Rwandan Minister of Health Ezechias Rwabuhihi, Rwandan Ambassador to the US Dr. Richard Sezibera and the Rwandan Director-General for AIDS and Social Affairs Chantal Kabagabo. On Thursday evening, Kagame held meetings with senior representatives from the National Institutes of Health, the Centres for Disease Control, World Health Organisation and UNAIDS.
010908
IR010919

Copyright © 2001 - Integrated Regional Information Networks (IRIN). Reproduction of this article (other than one copy for personal reference) must be cleared through the Integrated Regional Information Network. .

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980 – 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .